article · International Journal of Research in Medical Sciences
Background: The microvascular complications of diabetes correspond to diabetic microangiopathy including retinopathy, nephropathy and neuropathy. Few data are available on diabetic microangiopathy in Madagascar. The aims of the present study were to determine the prevalence of microangiopathy and their associated factors in a population of type 2 diabetics seen as outpatients in the Endocrinology Department of Joseph Raseta Befelatanana Hospital, in Antananarivo, Madagascar. Methods: Cross-sectional, descriptive and analytical study was conducted over a 6-month period. Retinopathy was diagnosed by specific abnormalities on fundus examination, nephropathy by albuminuria ≥30 mg/24h, and peripheral neuropathy by symmetrical distal sensory symptoms beginning in the lower limbs, a DN4 score ≥4/10 and/or impaired foot sensitivity. Results: Of the one hundred type 2 diabetics included in the study, sixty-two (62%) had presented with one or more diabetic microangiopathy. Associated factors were diabetes duration ≥10 years (OR=3.28; 95% CI: 1.17-9.22), abdominal obesity (OR=1.72; 95% CI: 1.06-2.77) and HbA1c >10% (OR=3.72; 95% CI: 1.02-13.48). Albuminuria was significantly higher in type 2 diabetics with microangiopathy than in without (p<0.01) while estimated glomerular function rate was significantly lower (p=0.04). Conclusions: Diabetic microangiopathy was frequent. Optimal management of hyperglycemia, obesity and associated cardiovascular risk factors is essential to avoid or limit their occurrence.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.18203/2320-6012.ijrms20250963
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.